Literature DB >> 11380597

Bone turnover markers and sex hormones in men with idiopathic osteoporosis.

P Pietschmann1, S Kudlacek, J Grisar, S Spitzauer, W Woloszczuk, R Willvonseder, M Peterlik.   

Abstract

BACKGROUND: In contrast to osteoporosis in postmenopausal women, osteoporosis in men has received much less attention. PATIENTS AND METHODS: We determined various biochemical parameters of bone metabolism and sex hormones in 31 men with idiopathic osteoporosis and 35 age matched control subjects.
RESULTS: In the men with osteoporosis, a significantly increased urinary excretion of deoxypyridinoline (5.3 +/- 0.2 vs. 4.6 +/- 0.2 nmol mmol-1 creatinine; P = 0.033) in addition to increased serum levels of the c-terminal telopeptide of type I collagen (2677 +/- 230 vs. 2058 +/- 153 pmol; P = 0.037) were found. While parameters of bone formation were not significantly different in the patients and controls, serum bone sialoprotein levels were significantly decreased in the patients (3.7 +/- 0.8 vs. 12.4 +/- 4.0 ng mL-1; P = 0.021). Moreover, in men with idiopathic osteoporosis, lower levels of estradiol (91.3 +/- 5.8 vs. 114.6 +/- 7.8 pmol L-1; P = 0.044), higher levels of sex hormone binding globulin (31.5 +/- 3.1 vs. 24.2 +/- 1.4 nmol L-1; P = 0.034) and a decreased free androgen index (42.6 +/- 5.2 vs. 56.4 +/- 5.9; P = 0.016) were seen. Serum estradiol levels correlated negatively with several parameters of bone resorption.
CONCLUSIONS: In men with idiopathic osteoporosis, bone resorption is increased and exceeds bone formation. The excessive bone resorption seen in idiopathic male osteoporosis may be due to decreased estradiol levels and low levels of bioavailable testosterone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380597     DOI: 10.1046/j.1365-2362.2001.00836.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  Heterogeneity of biological bone markers in idiopathic male osteoporosis.

Authors:  Michel Laroche
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

Review 2.  [Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer].

Authors:  Stefan Kudlacek; Thomas Puntus
Journal:  Wien Med Wochenschr       Date:  2012-08-09

3.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

4.  Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.

Authors:  W P Olszynski; K S Davison; G Ioannidis; J P Brown; D A Hanley; R G Josse; T M Murray; A Papaioannou; R J Sebaldt; A M Tenenhouse; A Petrie; C H Goldsmith; J D Adachi
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

Review 5.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

6.  Pattern of bone mineral density in idiopathic male osteoporosis.

Authors:  Michel Laroche
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

7.  Gender aspects of osteoporosis and bone strength.

Authors:  Janina M Patsch; Julia Deutschmann; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2011-03

8.  Muscle mass deficits are associated with bone mineral density in men with idiopathic vertebral fracture.

Authors:  J H Macdonald; S F Evans; M W J Davie; C A Sharp
Journal:  Osteoporos Int       Date:  2006-11-11       Impact factor: 4.507

9.  Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence.

Authors:  Ie-Wen Sim; Peter R Ebeling
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-10       Impact factor: 5.346

10.  Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis.

Authors:  Jun Li; Li Zhang; Liang Zhou; Zheng-Ping Yu; Feng Qi; Bei Liu; Su-Xia Zi; Li Li; Yi Li; San-Bin Wang; Zheng-Jiang Cui; Xing-Hua Pan
Journal:  J Transl Med       Date:  2012-05-21       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.